ATLAS

Ascentage Pharma Group International (AAPG) earnings date: expected December 1–7

Ascentage Pharma Group International (AAPG) has not announced its next earnings date yet. Based on its last 3 reports, ATLAS expects it around December 1–7. That is an estimate, not a confirmed date.

Source: company filings and exchange data · Updated Nov 2, 2026

ATLAS view on AAPG

Last price$13.80 (-4.6%)
Normal 1-day range (±1σ)±3.4%
Earnings beat historyBeat the EPS estimate in 3 of the last 4 reports

These figures come from the same calibrated model and valuation as the Ascentage Pharma Group International stock page. They describe an ordinary period, not the earnings reaction itself, which is usually wider and can go either way.

Get an email alert before AAPG reports

Expected around December 1–7 (estimate). One email the day before, with ATLAS’s read on Ascentage Pharma Group International. You can switch it off at any time.

Alert me before AAPG reports

Free to start. Creating an account takes under a minute.

Notify me when Ascentage Pharma Group International reports

Just your email. No account needed.

We'll email you before and after Ascentage Pharma Group International reports. You can unsubscribe at any time. Privacy

AAPG earnings at a glance

Next reportNot announced · expected around December 1–7 (ATLAS estimate)
Last reportJun 29, 2026 · Beat
Beat rate (last 4 reports)3 of 4 (75%)
Average EPS surprise+27.7%
Average move around a report±6.0% (last 4)
SectorHealthcare · Biotechnology

The expected window is an ATLAS estimate: it takes the typical gap between Ascentage Pharma Group International’s last 3 reports and adds it to the most recent one. Companies announce the real date a few weeks ahead, and ATLAS switches the page to the confirmed date as soon as it is published.

Ascentage Pharma Group International earnings history: last 4 reports

Ascentage Pharma Group International last reported on Jun 29, 2026: EPS of -$0.02 against an estimate of -$0.11 (+81.8% surprise), a beat.

Report dateEPS est.EPS actualSurpriseResultMove*
Jun 29, 2026-$0.11-$0.02+81.8%Beat+4.7%
Mar 31, 2026$0.59$0.66+11.9%Beat+13.5%
Feb 11, 2026$2.08$2.10+1.0%In line-3.3%
Jan 23, 2026$1.61$1.87+16.2%Beat-2.3%

*Move: change in the closing price from the last close before the report day to the close the day after it, so it captures the reaction whether the company reported before the open or after the close.

Get the full ATLAS analysis for AAPG

See the fair value, the probability range and the earnings history of Ascentage Pharma Group International on its ATLAS page.

Ascentage Pharma Group International (AAPG) stock analysis

Plans from €3.99 a month.

Ascentage Pharma Group International earnings: frequently asked questions

When is Ascentage Pharma Group International (AAPG) next earnings date?

Ascentage Pharma Group International has not announced its next report. Its last 3 reports came Jun 29, 2026, Mar 31, 2026, Jan 23, 2026, so ATLAS estimates the next one around December 1–7. This is an estimate based on that pattern, not a confirmed date.

How often does AAPG beat earnings estimates?

Of its last 4 reports with a recorded result, Ascentage Pharma Group International beat the EPS estimate 3 times; the average surprise was +27.7%. Past results do not predict the next one.

How much does AAPG move around earnings?

Over its last 4 reports the stock moved an average of 6.0% (absolute, from the close before the report day to the close after it), and finished higher 2 of 4 times.

Did Ascentage Pharma Group International beat earnings estimates last quarter?

Ascentage Pharma Group International last reported on Jun 29, 2026: EPS of -$0.02 against an estimate of -$0.11 (+81.8% surprise), a beat.

How much does AAPG usually move in a day?

On a normal trading day the ATLAS model puts AAPG’s one-day range at about ±3.4%, with a 50% chance of closing higher. This is not an options-implied earnings move; earnings days are usually wider.

Educational information, not investment advice. Disclaimer

ATLAS Signals

ATLAS Signals, every week

The week in the market, three stocks on ATLAS’s radar and what comes next. Get it every Monday.

By subscribing you agree to receive ATLAS Signals by email every Monday. You can unsubscribe with one click at any time. Privacy